Showing results (251-260 of 285) with videos related to
Sort By:
Pageof 29
Breast Cancer Research and Treatment|January 1, 1986
8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancerM E Lippman, R B Dickson, S Bates, et al.Molecular Endocrinology (Baltimore, Md.)|July 1, 1990
Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cellsD A Bronzert, S E Bates, J P Sheridan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of lifeS M Swain, J Rowland, K Weinfurt, et al.Molecular Endocrinology (Baltimore, Md.)|November 1, 1989
Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cellsB W Ennis, E M Valverius, S E Bates, et al.Journal of Cellular Physiology|March 1, 1992
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell linesE W Thompson, S Paik, N Brünner, et al.Breast Cancer Research and Treatment|July 19, 2017
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcomeP Miller, K M Kidwell, D Thomas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivoD Yang, C T Kuan, J Payne, et al.Cancer Research|May 1, 1979
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancerJ C Allegra, M E Lippman, E B Thompson, et al.Journal of the National Cancer Institute|September 25, 1998
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancerS Paik, J Bryant, C Park, et al.Cancer Research|May 1, 1986
Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7)M E McManaway, E M Jagoda, W C Eckelman, et al.Pageof 29